Biogen Acquires Apellis for $5.6B
Biogen acquired Apellis in May 2026 to expand Biogen’s presence in immunology and rare diseases.
Beam Therapeutics Enters into $500 Million Financing Agreement with Investment Firm Sixth Street
Beam will use the funding to further develop risto-cel.
Penn Engineering Researchers Use AI to Improve a Gene-Editing Tool
EvoMax uses experimental data to predict which modifications could improve the tool without having to test thousands of possibilities individually.
Penn Vet Researchers Invent Skin‑targeted Dual mRNA Vaccine Platform to Deliver Long‑lasting Protection Against Cutaneous Leishmaniasis
This experimental vaccine uses mRNA technology to train immune cells to recognize the parasite that causes cutaneous.
Penn Engineering researchers are developing new genetic technologies designed to make treating complex diseases simpler
In the field of bioengineering, Penn researchers are leveraging AI to improve gene editing tools and genetic engineering.
Penn Faculty Weighs in On the Future of American Science
John Wherry, PhD, the Richard and Barbara Schiffrin President's Distinguished Professor at Penn Medicine, explains how decades of federal funding for basic science enabled breakthroughs.
CAR T Cell Therapy for Lymphoma Leads to 10 Year Remissions for Patients
The follow-up study of patients ten years later showed promising results.
ARPA-H Awards $43 million to Philadelphia Gene Therapy Researchers to Advance Rare Disease Treatments
Learn more about the recipients.
Featured Technology: Leaf Sense
Cherie Kagan, PhD, the Stephen J. Angello Professor of Electrical and Systems Engineering at Penn Engineering, invented small, biodegradable leaf sensors that can measure the health of plants.
Network Bio Launches with $50 million in Funding to Create a Research Network of Large Biobanks to Drive AI Medical Research
Several U.S. Academic Medical Centers, including Penn Medicine, have partnered with Network Bio to generate large-scale multi-omic and multi-modal datasets.